Jaroslav Pochobradský
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jaroslav Pochobradský has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Jan Svoboda
Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentská 573, CZ532 10 Pardubice, Czech Republic
2 shared publications - Miloš Sedlák
Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic
2 shared publications - Alexander Čegan
Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentská 573, 532 10 Pardubice, Czech Republic
1 shared publication - Jan Bartáček
Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentská 573, Pardubice, 53210, Czechia
1 shared publication - Jiří Váňa
Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 95, 532 10 Pardubice, Czech Republic
1 shared publication Karel Macek
Univ Pardubice, Inst Organ Chem & Technol, Fac Chem Technol, Studentska 573, Pardubice 53210, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 14 April 2022
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 18 (1) , 438-445
The asymmetric Henry reaction as synthetic tool for the preparation of the drugs linezolid and rivaroxaban
The human drugs – the antibiotic linezolid (1) and the anticoagulant rivaroxaban (2) – belong among modern pharmaceutics, which contain an oxazolidine-2-one moiety bearing a stereogenic center. The chirality of these drugs is a fundamental attribute for their biological activity. Herein, one of the efficient asymmetric syntheses of these drugs was studied in detail. Highly enantioselective catalysts were tested in the key step of the synthetic procedure, i.e., the asymmetric Henry reaction, under different reaction conditions, using several starting aldehydes. The corresponding nitroaldols as chiral intermediates in the syntheses of these drugs were obtained in high yields and enantiomeric excesses of up to 91% ee.
- 14 April 2022
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 18 (1) , 438-445
Open AccessThe asymmetric Henry reaction as synthetic tool for the preparation of the drugs linezolid and rivaroxaban
The human drugs – the antibiotic linezolid (1) and the anticoagulant rivaroxaban (2) – belong among modern pharmaceutics, which contain an oxazolidine-2-one moiety bearing a stereogenic center. The chirality of these drugs is a fundamental attribute for their biological activity. Herein, one of the efficient asymmetric syntheses of these drugs was studied in detail. Highly enantioselective catalysts were tested in the key step of the synthetic procedure, i.e., the asymmetric Henry reaction, under different reaction conditions, using several starting aldehydes. The corresponding nitroaldols as chiral intermediates in the syntheses of these drugs were obtained in high yields and enantiomeric excesses of up to 91% ee.
- Open Access
- 10 May 2021
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 17 (1) , 1048-1085
Recent advances in palladium-catalysed asymmetric 1,4–additions of arylboronic acids to conjugated enones and chromones
The transition metal (palladium)-catalysed asymmetric 1,4-addition of arylboronic acids to conjugated enones belong to the most important and emerging strategies for the construction of C–C bonds in an asymmetric fashion. This review covers known catalytic systems used for this transformation. For clarity, we are using the type of ligand as a sorting criterion. Finally, we attempted to create a flowchart facilitating the selection of a suitable ligand for a given combination of enone and arylboronic acid.
- 10 May 2021
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 17 (1) , 1048-1085
Open AccessRecent advances in palladium-catalysed asymmetric 1,4–additions of arylboronic acids to conjugated enones and chromones
The transition metal (palladium)-catalysed asymmetric 1,4-addition of arylboronic acids to conjugated enones belong to the most important and emerging strategies for the construction of C–C bonds in an asymmetric fashion. This review covers known catalytic systems used for this transformation. For clarity, we are using the type of ligand as a sorting criterion. Finally, we attempted to create a flowchart facilitating the selection of a suitable ligand for a given combination of enone and arylboronic acid.